Formulation and performance evaluation of polymeric mixed micelles encapsulated with baicalein for breast cancer treatment

References

• Globocan Observatory. W. I., (IARC), I. A. for R. on C., (WHO) Breast Cancer. Source: Globocan 2018. World Health Organization International Agency for Research on Cancer W. H. O. 2019. 876. Available from: http://gco.iarc.fr/today%0Ahttps://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf
   Google Scholar
• Greenwell M, Rahman PKS. Europe PMC funders group medicinal plants : their use in anticancer treatment. Int J Pharm Sci Res. 2015;6(10):4103–4112.
   PubMed Web of Science ®Google Scholar
• Seca AML, Pinto DCGA. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. IJMS. 2018;19(1):263.
   Google Scholar
• Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev. 2009;35(1):57–68.
   PubMed Web of Science ®Google Scholar
• Gao Y, Snyder SA, Smith JN, et al. Anticancer properties of baicalein: a review. Med Chem Res. 2016;25(8):1515–1523.
   PubMed Web of Science ®Google Scholar
• Lee JH, Li YC, Ip SW, et al. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway. Anticancer Res. 2008;28(3A):1701–1711.
   PubMed Web of Science ®Google Scholar
• Wang L, Ling Y, Chen Y, et al. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 2010;297(1):42–48.
   PubMed Web of Science ®Google Scholar
• Chung H, Choi HS, Seo EK, et al. Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells. Biochem Biophys Res Commun. 2015;458(3):707–713.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Chang Q, et al. Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharm Res. 2005;22(7):1050–1058.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lv H, Jiang K, et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm. 2011;420(1):180–188.
   PubMed Web of Science ®Google Scholar
• He X, Pei L, Tong HHY, et al. Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with pluronic F68 to improve dissolution and oral bioavailability. AAPS PharmSciTech. 2011;12(1):104–113.
   PubMed Web of Science ®Google Scholar
• Yin J, Xiang C, Wang P, et al. Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability. Int J Nanomedicine. 2017;12:2923–2931.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhang Y, Wang B, et al. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems. Int J Nanomedicine. 2019;14:7291–7306.
   PubMed Web of Science ®Google Scholar
• Liang J, Wu W, Liu Q, et al. Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailability in vivo. Drug Deliv. 2013;20(8):319–323.
   PubMed Web of Science ®Google Scholar
• Shen H, Liu Y, Zhang H, et al. Enhancing the oral bioavailability of baicalein via Solutol® HS15 and poloxamer 188 mixed micelles system. J Pharm Pharmacol. 2019;71(5):765–773.
   PubMed Web of Science ®Google Scholar
• Gaucher G, Satturwar P, Jones MC, et al. Polymeric micelles for oral drug delivery. Eur J Pharm Biopharm. 2010;76(2):147–158.
   PubMed Web of Science ®Google Scholar
• Xu W, Ling P, Zhang T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv. 2013;2013:340315–340315.
   PubMedGoogle Scholar
• Alhakamy NA, Ahmed OAA, Fahmy UA, et al. Development and in vitro evaluation of 2-methoxyestradiol loaded polymeric micelles for enhancing anticancer activities in prostate cancer. Polymers. 2021;13(6):884.
   PubMed Web of Science ®Google Scholar
• Khonkarn R, Daowtak K, Okonogi S. Chemotherapeutic efficacy enhancement in P-gp-overexpressing cancer cells by flavonoid-loaded polymeric micelles. AAPS PharmSciTech. 2020; 21(4):121.
   PubMed Web of Science ®Google Scholar
• Alven S, Aderibigbe BA. The therapeutic efficacy of dendrimer and micelle formulations for breast cancer treatment. Pharmaceutics. 2020;12(12):1212–1249.
   Web of Science ®Google Scholar
• Yang C, Wu T, Qi Y, et al. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 2018;8(2):464–485.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block copolymers : evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 2008;130(2):98–106.
   PubMed Web of Science ®Google Scholar
• Barry AP, Barry NPE. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polym Chem. 2014;5(10):3291–3297.
   Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. Curcumin loaded mixed micelles composed of pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces. 2012;97:101–108.
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol. 2013;9(7):1146–1154.
   PubMed Web of Science ®Google Scholar
• Hao T, Chen D, Liu K, et al. Micelles of d-α-Tocopheryl polyethylene glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of multidrug resistance. ACS Appl Mater Interfaces. 2015;7(32):18064–18075.
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. The applications of vitamin e TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175–186.
   PubMed Web of Science ®Google Scholar
• Neophytou CM, Constantinou C, Papageorgis P, et al. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in survivin-overexpressing breast cancer cells. Biochem Pharmacol. 2014;89(1):31–42.
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, et al. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709–2728.
   PubMed Web of Science ®Google Scholar
• Werle M. Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm Res. 2008;25(3):500–511.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Y, Li C, et al. Pluronic P85/F68 micelles of baicalein could interfere with mitochondria to overcome MRP2-Mediated efflux and offer improved anti-Parkinsonian activity. Mol Pharmaceutics. 2017;14(10):3331–3342.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang S, Huang L, et al. Poly (ethylene glycol)-block-poly (D, L-lactide) (PEG-PLA) micelles for brain delivery of baicalein through nasal route for potential treatment of neurodegenerative diseases due to oxidative stress and inflammation: an in vitro and in vivo study. Int J Pharm. 2020;591:119981.
   PubMedGoogle Scholar
• You G, Feng T, Zhang G, et al. Preparation, optimization, characterization and in vitro release of baicalein-solubilizing glycyrrhizic acid nano-micelles. Int J Pharm. 2021;601:120546.
   PubMedGoogle Scholar
• Golombek EE, May JN, Theek B, et al. Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev. 2018;130:17–38.
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomedicine. 2012;7:713–721.
   PubMed Web of Science ®Google Scholar
• Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2013;65(1):71–79.
   PubMed Web of Science ®Google Scholar
• Butt AM, Amin MCIM, Katas H, et al. In vitro characterization of pluronic F127 and D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles as nanocarriers for targeted anticancer-drug delivery. J Nanomater. 2012;2012:1–11.
   Web of Science ®Google Scholar
• Gao Y, Li LB, Zhai G. Preparation and characterization of pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces. 2008;64(2):194–199.
   PubMed Web of Science ®Google Scholar
• Meng X, Liu J, Yu X, et al. Pluronic F127 and D-α-Tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier. Sci Rep. 2017;7(1):1–12.
   PubMedGoogle Scholar
• Ji S, Lin X, Yu E, et al. Curcumin-Loaded mixed micelles: preparation, characterization, and in vitro antitumor activity. J Nanotechnol. 2018;2018:1–9.
   Web of Science ®Google Scholar
• Melik-Nubarov NS, Pomaz OO, Dorodnych T, et al. Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers. FEBS Letters. 1999;446(1):194–3468.
   PubMed Web of Science ®Google Scholar
• Zhou Q-M, Wang S, Zhang H, et al. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol Sin. 2009;30(12):1648–1658.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
   PubMed Web of Science ®Google Scholar